Effect of Ivermectin in the Treatment of Coronavirus Disease 2019: A Trial Sequential Analysis Highlights the Requirement of Additional Randomized, Controlled Trials.

Padhi, Sunali; Pati, Abhijit; Panda, Aditya K

Padhi, Sunali; Pati, Abhijit; Panda, Aditya K.

Padhi S; Department of Bioscience and Bioinformatics, Khallikote University, Berhampur, Odisha, India.
Pati A; Department of Bioscience and Bioinformatics, Khallikote University, Berhampur, Odisha, India.
Panda AK; Department of Bioscience and Bioinformatics, Khallikote University, Berhampur, Odisha, India.

Clin Infect Dis ; 74(6): 1120-1121, 2022 03 23.

Article in English | MEDLINE | ID: covidwho-1702693

Subject(s)

COVID-19 Drug Treatment; Ivermectin; Antiviral Agents/therapeutic use; Humans; Ivermectin/therapeutic use; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ivermectin / COVID-19 Drug Treatment Type of study: Experimental Studies / Randomized controlled trials Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google